Phone interview and blood test
OtherSubjects will be interviewed about environmental, domestic and occupational exposures during several periods of life Two blood samples will be collected at enrollment to study genetic polymorphisms
NCT Number: NCT02109926
The incidence of testicular germ cell tumors, the most common cancer in men aged 15 to 45 years, has doubled in France in 30 years. Reasons remain unclear but a role of environmental factors, especially during critical periods of development, is strongly suspected. Reliable data on environmental exposure during this critical period are sparse.The discordant findings and the limitations of available studies underline the importance to conduct studies with sufficient statistical power to detect risk due to exposures during critical windows of vulnerability.
We conduct a multicentric case-control study to assess this association. Cases and controls will be enrolled during a 18-month period. They will be interviewed by professional telephone interviewers about their occupational and residential history and about their domestic exposure to pesticides and other nuisances.
An optional biological study to assess genetic polymorphisms known to be associated with testicular cancer will be proposed to every cases and controls.
Mothers (or close relative) of cases and controls will also be contacted (with son's agreement). If they agree to participate, they will also be interviewed about antenatal and early life exposure of their sons to pesticides and other nuisances.
Cases will be matched up with 2 controls (one of each group) both on age (+/- 2 years) and on recruiting center.
Looking for future studies?
Notify Me18 year–44 year
Male
Observational
CHRU Jean Minjoz, Besançon, France
Environmental exposure to pesticides will be assessed from subject's residential history, using a Geographic Information System.
Occupational exposure to pesticides and other nuisances will be assessed by an industrial hygienist who will be in charge to encode all subjects and mothers' occupations.
Domestic exposure to pesticides will be assessed from type, target and frequency of domestic pesticide use.
Based on these 3 sources of exposure, a score of exposition will be calculated for each case and each control.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be interviewed about environmental, domestic and occupational exposures during several periods of life Two blood samples will be collected at enrollment to study genetic polymorphisms
Time frame: at the end of enrollment (18 months)
Occupational, environmental and domestic exposures to pesticides and other nuisances will be assessed.
Time frame: at the end of enrollment (18 months)
The association will be assessed during antenatal, postnatal early life and later life (adolescence and adulthood).
Occupational, environmental and domestic exposures to pesticides and other nuisances will be assessed.
Time frame: one year after the end of enrollment
Polymorphisms involved in organochlorine metabolism pathways will also be assessed.
Biological study
Centre Leon Berard
Other
A Multicentric Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures During Antenatal and Early Postnatal Periods and the Risk to Develop a Testicular Germ Cell Tumor During Adulthood
Acronym: TESTIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03426865
Endocrine Gland Neoplasms, Endocrine System Diseases
Dallas, Texas, United States
View Trial DetailsNCT00104676
Carcinoma, Embryonal, Endocrine Gland Neoplasms
Houston, Texas, United States
View Trial DetailsNCT00003800
Carcinoma, Embryonal, Endocrine Gland Neoplasms
Chicago, Illinois, United States
View Trial DetailsNCT00003518
Adnexal Diseases, Endocrine Gland Neoplasms
Denver, Colorado, United States
View Trial Details